|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Nurix Therapeutics (NASDAQ: NRIX) through any online brokerage.
There are no as such competitors for Nurix Therapeutics.
The latest price target for Nurix Therapeutics (NASDAQ: NRIX) was reported by RBC Capital on April 30, 2021. The analyst firm set a price target for 42.00 expecting NRIX to rise to within 12 months (a possible 36.45% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Nurix Therapeutics (NASDAQ: NRIX) is $30.78 last updated Today at 8:00:02 PM.
There are no upcoming dividends for Nurix Therapeutics.
There is no upcoming split for Nurix Therapeutics.
Nurix Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.